medigraphic.com
ISSN 2539-0859 (Electronic)
ISSN 0120-8411 (Print)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)

2024, Number 3

<< Back Next >>

Acta de Otorrinolaringología CCC 2024; 52 (3)

Guidelines for the diagnosis and treatment of Epistaxis

Pinzón-Navarro MA, Torres-Riaño MP, Martínez-Manjarrés MM

Language: Spanish
References: 20
Page: 221-248
PDF size: 727.22 Kb.


ABSTRACT

Introduction: Epistaxis, or nasal bleeding, is a common condition that can range from mild, self-limiting episodes to severe cases requiring urgent medical intervention. Despite its frequency, epistaxis can present significant clinical challenges due to its wide range of underlying causes and the need for a systematic approach to management. This clinical practice guideline is designed to provide a comprehensive and evidence-based approach to the diagnosis, treatment, and prevention of epistaxis. Its purpose is to assist healthcare professionals in making informed decisions, optimizing patient care, and improving clinical outcomes.


REFERENCES

  1. Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y Cuello. Guía de manejo de epistaxis; 2015. Bogotá: ACORL

  2. National ENT Trainee Research Network. Epistaxis 2016: national audit of management. J Laryngol Otol. 2017;131(12):1131-1141.doi: 10.1017/S002221511700202X

  3. Khan M, Conroy K, Ubayasiri K, et al. Initial assessment in the management of adult epistaxis: systematic review. J Laryngol Otol.2017;131(12):1035-1055. doi: 10.1017/S0022215117002031

  4. Tunkel DE, Anne S, Payne SC, et al. Clinical Practice Guideline: Nosebleed (Epistaxis). Otolaryngol Head Neck Surg. 202;162(1_suppl):S1-S38. doi: 10.1177/0194599819890327

  5. Record S. Practice Guideline: Epistaxis in Children. J Pediatr Health Care. 2015;29(5):484-8. doi: 10.1016/j.pedhc.2015.06.002

  6. Bequignon E, Vérillaud B, Robard L, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment ofepistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(3):185-189. doi: 10.1016/j.anorl.2016.09.008

  7. Verillaud B, Robard L, Michel J, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). Second-line treatment ofepistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(3):191-193. doi: 10.1016/j.anorl.2016.09.009

  8. Robard L, Michel J, Prulière Escabasse V, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL) (short version).Specific treatment of epistaxis in Rendu-Osler-Weber disease. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(1):37-41. doi:10.1016/j.anorl.2016.09.010

  9. Michel J, Prulière Escabasse V, Bequignon E, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). Epistaxis andhigh blood pressure. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(1):33-35. doi: 10.1016/j.anorl.2016.09.011

  10. Escabasse V, Bequignon E, Vérillaud B, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). Managing epistaxisunder coagulation disorder due to antithrombotic therapy. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(3):195-199. doi:10.1016/j.anorl.2016.10.001

  11. Krempl GA, Noorily AD. Use of oxymetazoline in the management of epistaxis. Ann Otol Rhinol Laryngol. 1995;104(9 Pt 1):704-6.doi: 10.1177/000348949510400906

  12. Hajimaghsoudi M, Largani HA, Baradaranfar MH, et al. A novel method for epistaxis management: Randomized clinical trial comparingnose clip with manual compression. Am J Emerg Med. 2018;36(1):149-150. doi: 10.1016/j.ajem.2017.07.025

  13. Mathiasen RA, Cruz RM. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acuteanterior epistaxis. Laryngoscope. 2005;115(5):899-902. doi: 10.1097/01.MLG.0000160528.50017.3C

  14. McClurg SW, Carrau R. Endoscopic management of posterior epistaxis: a review. Acta Otorhinolaryngol Ital. 2014;34(1):1-8.

  15. Mehanna H, Abdelkader M, Albahnasawy L, et al. Early discharge following nasal pack removal: is it feasible? Clin Otolaryngol AlliedSci. 2002;27(3):153-155. doi: 10.1046/j.1365-2273.2002.00552.x

  16. Sanders YV, Fijnvandraat K, Boender J, et al. Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevanceof pediatric-specific bleeding. Am J Hematol. 2015;90(12):1142-8. doi: 10.1002/ajh.24195

  17. Altomare I, Cetin K, Wetten S, et al. Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: aretrospective cohort study using a large administrative medical claims database in the US. Clin Epidemiol. 2016;8:231-9. doi: 10.2147/CLEP.S105888

  18. Sarhan NA, Algamal AM. Relationship between epistaxis and hypertension: A cause and effect or coincidence? J Saudi Heart Assoc.2015;27(2):79-84. doi: 10.1016/j.jsha.2014.09.002

  19. Bellew SD, Johnson KL, Nichols MD, et al. Effect of Intranasal Vasoconstrictors on Blood Pressure: A Randomized, Double-Blind,Placebo-Controlled Trial. J Emerg Med. 2018;55(4):455-464. doi: 10.1016/j.jemermed.2018.07.004

  20. Brinjikji W, Kallmes DF, Cloft HJ. Trends in epistaxis embolization in the United States: a study of the Nationwide Inpatient Sample2003-2010. J Vasc Interv Radiol. 2013;24(7):969-73. doi: 10.1016/j.jvir.2013.02.035




2020     |     www.medigraphic.com